COMPOSITIONS AND METHOD OF CANCER STEM CELL INHIBITION

MA43342AUndetermined Publication Date: 2018-08-08MEDIMMUNE LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA43342
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2015-09-30
Filing Date: 2016-09-29
Publication Date: 2018-08-08

Application Information

Patent Timeline

30 Sep 2015

Priority

29 Sep 2016

Application

MA43342

08 Aug 2018

Publication

MA43342A

IPC: C07K16/28; A61P35/00; G01N33/574

CPC: C07K16/2851; C07K16/30; C12N5/0695; A61K2039/505; C07K2317/76; C07K2318/00; C12Q1/25; A61K31/704

Inventors: HURT ELAINE M; KARATHANASIS SOTIRIOS

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates generally to compositions and methods useful in the treatment of cancer. More specifically, the methods and compositions can be used to detect, quantify, inhibit, kill, differentiate or eliminate cancer stem cells (cscs) and can be used in the treatment of cancers associated with cscs, in particular cancers and cscs that express lox1.

Need to check novelty before this filing date? Find Prior Art